In a recent post, we talked about the debilitating effects of diabetic autonomic neuropathy (DAN) and perhaps the most serious side-effect of it – cardiovascular autonomic neuropathy (CAN). Using information in an article by the American Diabetes Association, we helped you understand what DAN is and how it’s treated.
Today, we’re going to talk about CAN – what it is and how it’s easier than ever for physicians to detect and monitor with our critical care test.
Before moving on, though, it’s important to understand that diabetic and cardiovascular neuropathy don’t exist on the same plane. In other words, you often get one before you get the other and the process usually begins with diabetes.
The process looks like this: Diabetes –> Diabetic Neuropathy –> Cardiovascular Neuropathy